These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 11343704)

  • 1. Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase-2').
    Sarno S; Reddy H; Meggio F; Ruzzene M; Davies SP; Donella-Deana A; Shugar D; Pinna LA
    FEBS Lett; 2001 May; 496(1):44-8. PubMed ID: 11343704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural features underlying selective inhibition of protein kinase CK2 by ATP site-directed tetrabromo-2-benzotriazole.
    Battistutta R; De Moliner E; Sarno S; Zanotti G; Pinna LA
    Protein Sci; 2001 Nov; 10(11):2200-6. PubMed ID: 11604527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward the rational design of protein kinase casein kinase-2 inhibitors.
    Sarno S; Moro S; Meggio F; Zagotto G; Dal Ben D; Ghisellini P; Battistutta R; Zanotti G; Pinna LA
    Pharmacol Ther; 2002; 93(2-3):159-68. PubMed ID: 12191608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2.
    Pagano MA; Meggio F; Ruzzene M; Andrzejewska M; Kazimierczuk Z; Pinna LA
    Biochem Biophys Res Commun; 2004 Sep; 321(4):1040-4. PubMed ID: 15358133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative binding modes of an inhibitor to two different kinases.
    De Moliner E; Brown NR; Johnson LN
    Eur J Biochem; 2003 Aug; 270(15):3174-81. PubMed ID: 12869192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emodin, an anthraquinone derivative isolated from the rhizomes of Rheum palmatum, selectively inhibits the activity of casein kinase II as a competitive inhibitor.
    Yim H; Lee YH; Lee CH; Lee SK
    Planta Med; 1999 Feb; 65(1):9-13. PubMed ID: 10083837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells.
    Ruzzene M; Penzo D; Pinna LA
    Biochem J; 2002 May; 364(Pt 1):41-7. PubMed ID: 11988074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The replacement of ATP by the competitive inhibitor emodin induces conformational modifications in the catalytic site of protein kinase CK2.
    Battistutta R; Sarno S; De Moliner E; Papinutto E; Zanotti G; Pinna LA
    J Biol Chem; 2000 Sep; 275(38):29618-22. PubMed ID: 10882732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2.
    Cozza G; Mazzorana M; Papinutto E; Bain J; Elliott M; di Maira G; Gianoncelli A; Pagano MA; Sarno S; Ruzzene M; Battistutta R; Meggio F; Moro S; Zagotto G; Pinna LA
    Biochem J; 2009 Jul; 421(3):387-95. PubMed ID: 19432557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different susceptibility of protein kinases to staurosporine inhibition. Kinetic studies and molecular bases for the resistance of protein kinase CK2.
    Meggio F; Donella Deana A; Ruzzene M; Brunati AM; Cesaro L; Guerra B; Meyer T; Mett H; Fabbro D; Furet P
    Eur J Biochem; 1995 Nov; 234(1):317-22. PubMed ID: 8529658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selectivity of 4,5,6,7-tetrabromobenzimidazole as an ATP-competitive potent inhibitor of protein kinase CK2 from various sources.
    Zień P; Bretner M; Zastapiło K; Szyszka R; Shugar D
    Biochem Biophys Res Commun; 2003 Jun; 306(1):129-33. PubMed ID: 12788077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase CK2 phosphorylates the cell cycle regulatory protein Geminin.
    Kulartz M; Hiller E; Kappes F; Pinna LA; Knippers R
    Biochem Biophys Res Commun; 2004 Mar; 315(4):1011-7. PubMed ID: 14985113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and exploitation of CK2 inhibitors.
    Sarno S; Ruzzene M; Frascella P; Pagano MA; Meggio F; Zambon A; Mazzorana M; Di Maira G; Lucchini V; Pinna LA
    Mol Cell Biochem; 2005 Jun; 274(1-2):69-76. PubMed ID: 16335530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The selectivity of inhibitors of protein kinase CK2: an update.
    Pagano MA; Bain J; Kazimierczuk Z; Sarno S; Ruzzene M; Di Maira G; Elliott M; Orzeszko A; Cozza G; Meggio F; Pinna LA
    Biochem J; 2008 Nov; 415(3):353-65. PubMed ID: 18588507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of protein kinase CK2 by condensed polyphenolic derivatives. An in vitro and in vivo study.
    Meggio F; Pagano MA; Moro S; Zagotto G; Ruzzene M; Sarno S; Cozza G; Bain J; Elliott M; Deana AD; Brunati AM; Pinna LA
    Biochemistry; 2004 Oct; 43(40):12931-6. PubMed ID: 15461466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).
    Sarno S; de Moliner E; Ruzzene M; Pagano MA; Battistutta R; Bain J; Fabbro D; Schoepfer J; Elliott M; Furet P; Meggio F; Zanotti G; Pinna LA
    Biochem J; 2003 Sep; 374(Pt 3):639-46. PubMed ID: 12816539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of protein kinase CK2 as a potent kinase of Epstein-Barr virus latent membrane protein 1.
    Chi LM; Yu JS; Chang YS
    Biochem Biophys Res Commun; 2002 Jun; 294(3):586-91. PubMed ID: 12056807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrabromocinnamic acid (TBCA) and related compounds represent a new class of specific protein kinase CK2 inhibitors.
    Pagano MA; Poletto G; Di Maira G; Cozza G; Ruzzene M; Sarno S; Bain J; Elliott M; Moro S; Zagotto G; Meggio F; Pinna LA
    Chembiochem; 2007 Jan; 8(1):129-39. PubMed ID: 17133643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical proteomics and functional proteomics strategies for protein kinase inhibitor validation and protein kinase substrate identification: applications to protein kinase CK2.
    Gyenis L; Turowec JP; Bretner M; Litchfield DW
    Biochim Biophys Acta; 2013 Jul; 1834(7):1352-8. PubMed ID: 23416530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of synthetic fragments of inhibitor-2 of protein phosphatase-1 by casein kinase-1 and -2. Evidence that phosphorylated residues are not strictly required for efficient targeting by casein kinase-1.
    Marin O; Meggio F; Sarno S; Andretta M; Pinna LA
    Eur J Biochem; 1994 Jul; 223(2):647-53. PubMed ID: 8055935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.